Keyword Connections

multiple sclerosis

Journals

53

1 the journal of nutrition

2 Medicine

3 Journal of medical Internet research

4 International journal of qualitative studies on health and well-being

5 JAMA pediatrics

6 journal of molecular graphics & modelling

7 Anatolian journal of cardiology

8 the british journal of dermatology

9 European radiology

10 JAMA

11 annals of internal medicine

12 Patient education and counseling

13 medicines (basel, switzerland)

14 neuroimage clinical

15 value in health regional issues

16 medical hypotheses

17 behavioural processes

18 Endocrine

19 clinical neurophysiology : official journal of the international federation of clinical neurophysiology

20 journal of child neurology

21 gait & posture

22 health (london, england : 1997)

23 human gene therapy

24 Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP)

25 Current biology : CB

26 The journal of sexual medicine

27 Digital health

28 therapeutic advances in neurological disorders

29 American journal of ophthalmology

30 clinica chimica acta; international journal of clinical chemistry

31 the journal of endocrinology

32 frontiers in neurology

33 physiological measurement

34 pm & r : the journal of injury, function, and rehabilitation

35 Diagnostics (Basel, Switzerland)

36 turkish journal of physical medicine and rehabilitation

37 clinical neurology and neurosurgery

38 Medical image analysis

39 neuropsychological rehabilitation

40 European Neurology

41 Multiple sclerosis and related disorders

42 journal of molecular medicine (berlin, germany)

43 Anaesthesia

44 journal of neurology

45 acta neurologica scandinavica

46 nutritional neuroscience

47 multiple sclerosis (houndmills, basingstoke, england)

48 journal of neurology, neurosurgery, and psychiatry

49 ACS biomaterials science & engineering

50 neurorehabilitation

51 Handbook of clinical neurology

52 neuroimaging clinics of north america

53 iranian journal of neurology

Research Groups

0

No Research Group Connected

Bibliographies

295

1 Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.

2 Randomized controlled trial of SystemCHANGE™ weight management intervention in neurological conditions.

3 Auditory brainstem response.

4 Self-regulation of brain activity and its effect on cognitive function in patients with multiple sclerosis - First insights from an interventional study using neurofeedback.

5 Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives.

6 Constraint-induced movement therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.

7 The association between gait variability with the energy cost of walking depends on the fall status in people with multiple sclerosis without mobility aids.

8 Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study.

9 Association Between Dialysis Facility Ownership and Access to Kidney Transplantation.

10 Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P receptor agonists.

11 Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.

12 Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait.

13 Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis.

14 Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis.

15 Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia.

16 Modern banking, collection, compatibility testing and storage of blood and blood components.

17 Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis.

18 Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study.

19 Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.

20 Visual Function and Disability are Associated with Increased Retinal Volumetric Vessel Density in Patients with Multiple Sclerosis.

21 Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.

22 A changed life: The life experiences of patients with psoriasis receiving biological treatment.

23 Self-Reported Changes in Cognition, Communication and Swallowing in Multiple Sclerosis: Data from the Swedish Multiple Sclerosis Registry and from a National Survey.

24 Upper and lower limb performance fatigability in persons with multiple sclerosis investigated through surface electromyography: a pilot study.

25 Herpes viruses in optic neuritis: Similar to Bell's palsy.

26 Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia.

27 Automated volumetric assessment with artificial neural networks might enable a more accurate assessment of disease burden in patients with multiple sclerosis.

28 Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?

29 Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams.

30 Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.

31 Adjusting to living with multiple sclerosis: The role of social groups.

32 Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.

33 Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?

34 Fully automated longitudinal segmentation of new or enlarged multiple sclerosis lesions using 3D convolutional neural networks.

35 Neural implant for the treatment of multiple sclerosis.

36 Diverse Applications of Artificial Intelligence in Neuroradiology.

37 sexual therapy for women with multiple sclerosis and its impact on quality of life

38 targeting cognitive impairment in multiple sclerosis—the road toward an imaging-based biomarker

39 dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations

40 impact of natalizumab treatment on fatigue, mood and aspects of cognition in relapsing-remitting multiple sclerosis

41 guardian ad litem, a potentially expensive invitation to either the mismanagement or management of patients with cognitive disorders

42 magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients

43 paroxysmal dysphasia in a 68 year-old man: enhancing the mri spectrum!

44 effect of combined mental and physical training on the targeting accuracy of patients with multiple sclerosis

45 b cells are multifunctional players in multiple sclerosis pathogenesis: insights from therapeutic interventions

46 exploring the role of microglia in mood disorders associated with experimental multiple sclerosis

47 Title not found

48 differential expression of <i>smad</i> genes and <i>s1pr1</i> on circulating cd4+ t cells in multiple sclerosis and crohn’s disease

49 polymorphism of apo lipoprotein e gene and the risk of multiple sclerosis

50 evaluation of visual-evoked cerebral metabolic rate of oxygen as a diagnostic marker in multiple sclerosis

51 the physicochemical and thermodynamic properties of the choline chloride-based deep eutectic solvents

52 cerebellar dysfunction in multiple sclerosis

53 motor evoked potentials modification in different forms and stages of multiple sclerosis

54 a new method for segmentation of multiple sclerosis (ms) lesions on brain mr images

55 quality of life, coping, and social support in patients with multiple sclerosis: a pilot study

56 the evaluation of serum testostrone level in reproductive age women with multiple sclerosis and its relation with disease severity

57 regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant

58 immunological markers for pml prediction in ms patients treated with natalizumab

59 understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the alemtuzumab clinical development program

60 structural networks involved in attention and executive functions in multiple sclerosis

61 determination of soluble icam-1 and tnfalphar in the cerebrospinal fluid and serum levels in a population of brazilian patients with relapsing-remitting multiple sclerosis determinação dos níveis de icam-1 e tnfalfar solúvel no líquido cefalorraqueano e soro numa população de pacientes brasileiros com esclerose múltipla forma surto-remissão

62 characterization of the first symptoms of multiple sclerosis in a brazilian center: cross-sectional study

63 a study of psychological well-being in people with multiple sclerosis and their primary caregivers

64 the representation of inflammatory signals in the brain – a model for subjective fatigue in multiple sclerosis

65 psychiatric disorders in multiple sclerosis patients transtornos psiquiátricos em pacientes com esclerose múltipla

66 repopulation of t, b, and nk cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

67 the role of information system in multiple sclerosis management

68 ccl5–glutamate cross-talk in astrocyte-neuron communication in multiple sclerosis

69 analysis of plasminogen genetic variants in multiple sclerosis patients

70 investigating negotiated treatment goals as a tool to facilitate collaboration between conventional and complementary practitioners in the treatment of people with multiple sclerosis

71 development of a sensitive outcome for economical drug screening for progressive multiple sclerosis treatment

72 corrigendum: high-resolution spectral domain-optical coherence tomography in multiple sclerosis, part ii - the total macular volume. the first follow-up study over 2 years.

73 multiple sclerosis and the comparative value disease modifying therapy report of the institute for clinical and economic review (icer)

74 understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models

75 mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults

76 matrix metalloproteinases, synaptic injury, and multiple sclerosis

77 the role of t1-weighted derived measures of neurodegeneration for assessing disability progression in multiple sclerosis

78 1,25-dihydroxyvitamin d3 conditioned cd11c+ dendritic cells are effective initiators of cns autoimmune disease

79 oligoclonal igg bands in the cerebrospinal fluid of portuguese patients with multiple sclerosis: negative results indicate benign disease bandas oligoclonais da igg no líquido céfalo-raquidiano de doentes portugueses com esclerose múltipla: resultados negativos indicam doença benigna

80 successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

81 new multiple sclerosis disease severity scale predicts future accumulation of disability

82 jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis

83 serum levels of brain-derived neurotrophicfactor correlate with the number of t2 mri lesions in multiple sclerosis

84 suppression of inflammatory demyelinaton and axon degeneration through inhibiting kv3 channels

85 diffusion tensor imaging of the cervical spinal cord of patients with relapsing-remising multiple sclerosis: a study of 41 cases imagens por tensor de difusão da medula cervical de pacientes com esclerose múltipla remitente-recorrente: estudo de 41 casos

86 prolactin and autoimmunity

87 therapeutic inertia in the new landscape of multiple sclerosis care

88 long-term change in central corneal thickness from a glaucoma perspective

89 brain mri in patients with multiple sclerosis with oligoclonal cerebrospinal fluid bands

90 cytokines stimulate the release of microvesicles from myeloid cells independently from the p2x7 receptor/acid sphingomyelinase pathway

91 the contribution of optical coherence tomography in neuromyelitis optica spectrum disorders

92 difference in motor fatigue between patients with stroke and patients with multiple sclerosis: a pilot study

93 polyunsaturated fatty acids for multiple sclerosis treatment

94 myelin basic protein and a multiple sclerosis-related mbp-peptide bind to oligonucleotides

95 myeloid extracellular vesicles: messengers from the demented brain

96 update on riboflavin and multiple sclerosis: a systematic review

97 manifestações oculares em pacientes com esclerose múltipla em são paulo ocular manifestations in patients with multiple sclerosis in são paulo

98 monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis

99 is there an increased risk for ischemic stroke in patients with multiple sclerosis, and if so, should preventive treatment be considered?

100 dopaminergic stimulation of myeloid antigen-presenting cells attenuates signal transducer and activator of transcription 3-activation favouring the development of experimental autoimmune encephalomyelitis

101 circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: a case-control study